GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » YoY EBITDA Growth

U-Neuron Biomedical (ROCO:6973) YoY EBITDA Growth : 43.68% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. U-Neuron Biomedical's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 43.68%.

U-Neuron Biomedical's EBITDA per Share for the six months ended in Dec. 2023 was NT$-0.86.

U-Neuron Biomedical YoY EBITDA Growth Historical Data

The historical data trend for U-Neuron Biomedical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical YoY EBITDA Growth Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- - -187.83 -28.83

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth - - - -94.01 43.68

U-Neuron Biomedical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

U-Neuron Biomedical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-3.137--2.435)/ | -2.435 |
=-28.83 %

U-Neuron Biomedical's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.855--1.518)/ | -1.518 |
=43.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » YoY EBITDA Growth
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://en.u-neuron.com
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines